SpecGx, LLC

Form 483 issued September 18, 2023 · Webster Groves, Missouri

Inspection
Sep 11 – Sep 18, 2023
Investigator
Monica E. Murie
Observations
2
Pages
3
FEI number
3005275960

In short: On September 18, 2023, FDA issued a Form 483 with 2 observations to SpecGx, LLC in Webster Groves, Missouri (FEI 3005275960) after an inspection that ran Sep 11 – Sep 18, 2023. The investigator was Monica E. Murie. Most observations concern production and quality system; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

Production and quality system account for 2 of 2 observations.

Production1
Quality system1

Most cited: 21 CFR 211.113 (1×) · 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures designed to prevent objectionable microorganisms in drug products not required to be sterile are…

  2. 02

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at SpecGx, LLC?

FDA listed 2 observations on this Form 483, mostly about production and quality system. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected SpecGx, LLC?

Monica E. Murie is named on this Form 483, for the inspection of Sep 11 – Sep 18, 2023. Each investigator has a profile showing what they cite most.

When was SpecGx, LLC inspected by FDA?

The inspection ran Sep 11 – Sep 18, 2023, and the Form 483 is dated September 18, 2023.

How do I get the full Form 483 for SpecGx, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free